Abstract
Enhanced recovery after surgery (ERAS) programs have been developed by combining several evidence-based techniques for perioperative care, with the intention of reducing the stress response and organ dysfunction, thus allowing improved clinical results. ERAS programs have been widely adopted for colorectal surgery; however, their adoption for upper gastrointestinal surgery has been challenging even though good results have been reported in the literature. Our intent was to investigate the adoption of ERAS programs for resective gastric surgery in Italy. A survey was conducted among 20 departments of surgery belonging to the Italian Group for Research on Gastric Cancer (GC). Analysis of our survey showed that several evidence-based practices and many items of the ERAS guidelines for gastric surgery are not implemented in real practice in Italian centers dedicated to GC. This situation may be related to the hesitation of surgeons to introduce radical changes to the traditional postoperative management after gastrectomy. A multidisciplinary approach to the perioperative care of these patients is not routinely applied in many Italian centers. A strict collaboration of all clinicians involved in the perioperative care of patients undergoing gastrectomy for GC is key for the future implementation of ERAS in gastric surgery in our departments.
Keywords: Enhanced recovery after surgery, Gastrectomy, Gastric cancer
Introduction
The worldwide incidence of gastric cancer (GC) has declined over the last decades, but it still remains one of the most common and lethal cancers [1, 2]. Surgery is the mainstay of treatment for localized disease [3]. Radical gastrectomy is a delicate operation with a postoperative 30-day mortality rate between 1 and 5% and a morbidity rate ranging from 10 to 40% [4, 5].
To improve the results of surgery, particular attention has been dedicated to improving perioperative care. Enhanced recovery after surgery (ERAS) programs have been developed by combining several evidence-based techniques for perioperative care with the intention of reducing the stress response and organ dysfunction [6]. Implementation of ERAS programs is intended to shorten the time required for full recovery and reduce postoperative complications associated with an excessive response to surgical stress without increasing postoperative morbidity.
Attention to perioperative care may have a major influence on morbidity after gastrectomy, and comprehensive pathways such as ERAS standardized protocols may be effective in improving the clinical course with subsequent economic benefits on health care systems [7]. ERAS protocols for perioperative care have proven valuable in reducing complications after surgery, improving overall outcomes, and shortening the length of stay, thus also saving resources [6]. A significant reduction in the postoperative length of stay after both open and laparoscopic gastrectomy, a reduction in the cost of surgery with similar morbidity and mortality, and a possible advantage in survival have been reported in several cases after application of an ERAS program for the care of patients undergoing radical gastrectomy [8–10]. Notwithstanding these results, it has been more difficult to apply ERAS programs to gastric surgery in clinical practice compared to what happened for colorectal surgery, mainly due to the need to introduce radical changes to the traditional postoperative management after gastrectomy.
Therefore, we were interested in determining the present rate of implementation of ERAS protocols for elective gastric resection for malignancy in Italy. To this end, we prepared and distributed a specific survey on this topic. This work reports the results of the survey.
Methods
This survey was conducted and proposed to several departments of surgery belonging to the Italian Group for Research on Gastric Cancer (GIRCG). These centers specialize in the treatment and management of patients with GC. The survey was composed of a two-part questionnaire that was sent to participating centers: the first part of the questionnaire included questions regarding general information about the department and the respective annual volume of resective GC surgery; the second part specifically concerned the implementation of ERAS protocols in the management of patients undergoing GC surgery (Supplementary Table 1). The questionnaire was designed in electronic format and sent by email to the heads of the selected surgery units. The survey was conducted between February and March 2021.
Results
Twenty centers (mostly located in northern Italy) from 9 Italian regions completed and returned the questionnaires. In total, 684 gastrectomies were reportedly performed in 2020. Table 1 reports the annual volume of gastric resective surgery among the centers. Only 1 center (5%) performed more than 100 gastrectomies, 4 (20%) centers performed between 50 and 99 resections, 7 (35%) centers between 25 and 49, and 8 (40%) centers performed less than 25. At the time of the questionnaire, a structured protocol for the management of patients undergoing GC surgery was present in 13 (65%) surgical departments. Among these 13 centers, only 5 (38,5%) declared that the ERAS items of this protocol were shared by surgeons, anesthesiologists, and nurses; in the remaining cases (61.5%), the definition and application of the items composing the ERAS protocol were either at complete discretion of the single healthcare professional or not included in the perioperative routine. In 15 of the 20 centers (75%), each professional figure was independently responsible for application of the various items without a shared structured protocol.
Table 1.
Annual volume of gastric resective surgery among centers
| Gastrectomies per year | Number of centers (%) |
|---|---|
| < 25 | 8 (40) |
| 25–49 | 7 (35) |
| 50–99 | 4 (20) |
| > 100 | 1 (5) |
Table 2 reports the answers concerning the preoperative item of the ERAS protocol. All respondents answered that they performed a preoperative nutritional risk assessment with different tools, mainly using the nutritional risk score [11]. A dietary assessment was routinely considered in 4 (20%) centers; it was performed only in case of diagnosis of malnutrition in 15 (75%) centers and never in 1 center (5%). Routine preoperative administration of immunonutrition and carbohydrate-rich drinks were applied in only six centers (30%), whereas in seven centers, these nutritional interventions were considered only selectively [Fig. 1]. Surprisingly, regarding preoperative fasting, solid food was allowed until 6 h before surgery in four centers (20%), whereas liquids were allowed until 2 h before surgery in only three of these centers (15%).
Table 2.
Preoperative items
| Nutritional risk assessment | 20 (100) | |
| NRS | 6 (30) | |
| MUST | 2 (10) | |
| MNA | 2 (10) | |
| NRI | 1 (5) | |
| Other | 9 (45) | |
| Dietary evaluation | ||
| Always | 4 (20) | |
| Only if malnutrition | 15 (75) | |
| Never | 1 (5) | |
| Preoperative fasting (hours) | ||
| solids | liquids | |
| 2 | 3 (15) | |
| 6 | 4 (20) | 9 (40) |
| 8 | 7 (35) | 6 (25) |
| 12 | 7 (35) | 2 (10) |
| From midnight | 1 (5) | |
| 24 | 1 (5) | |
| In patients without outlet obstruction or diabetes | ||
| Immunonutrition | ||
| Yes | 6 (30) | |
| Sometimes | 7 (35) | |
| No | 7 (35) | |
| Administration of carbohydrate-rich drink before surgery | ||
| Yes | 6 (30) | |
| Sometimes | 2 (10) | |
| No | 12 (60) | |
Fig. 1.

Administration of carbohydrate-rich drink before surgery and immunonutrition
The intraoperative items are addressed in Table 3. The attitude of different centers in respect to specific intraoperative surgical items was very dishomogeneous: in 60% of centers, a nasogastric tube was inserted either in all gastric resections (50%) or selectively based on the type of resection (15%), and abdominal drainage was considered routine in 75% of centers [Fig. 2]. A jejunostomy or naso-jejunal feeding tube was considered in cases of malnourished patients in 50% of centers, with 30% using it routinely in cases of total gastrectomy. Minimally invasive surgery was routinely considered for gastric resection for cancer by four centers (20%), whereas 30% of the centers included in this survey never or occasionally considered it [Fig. 3]. Among other intraoperative items in 25% of centers, placement of a central venous catheter and epidural analgesia were considered a routine. Measures to maintain intraoperative normothermia were used by all participants. The policy for intraoperative fluid administration was dictated by goal-directed fluid management by six (30%) respondents. In the other cases, fluid administration was restrictive in 20% of centers and guided by diuresis and central venous pressure in 30% of centers.
Table 3.
Intraoperative items
| Prophylactic antibiotics n° of centers (%) | |
| UST | 12 (60) |
| ST | 6 (30) |
| Until or beyond POD 1 | 2 (10) |
| CVC | |
| Non-routine | 15 (75) |
| Routine | 5 (25) |
| Epidural analgesia | |
| Always | 5 (25) |
| If open surgery | 10 (50) |
| Sometimes | 4 (20) |
| Never | 1 (5) |
| Maintaining intraoperative normothermia | 20 (100) |
| Fluid management | |
| GDFT | 6 (30) |
| Restrictive | 4 (20) |
| CVP and diuresis | 6 (30) |
| Other | 4 (20) |
| Nasogastric tube insertion | |
| Never | 5 (25) |
| Only for total gastrectomy | 3 (15) |
| Only for distal gastrectomy | 3 (15) |
| Always | 9 (45) |
| Abdominal drainage | |
| No insertion | 1 (5) |
| Selective insertion | 4 (20) |
| Routine insertion | 15 (75) |
| Jejunostomy or naso-jejunal feeding tube | |
| Always | 1 (5) |
| Only for total gastrectomy | 6 (30) |
| Only if malnutrition | 10 (50) |
| Never | 3 (15) |
| Minimally invasive surgery | |
| Routine | 4 (20) |
| Only for distal gastrectomies | 6 (30) |
| Only for early stages | 3 (15) |
| Occasionally | 4 (20) |
| Never | 3 (15) |
Fig. 2.

Postoperative nasogastric tube insertion
Fig.3.

Minimally invasive surgery
Answers to questions regarding postoperative items are reported in Table 4. In most centers, early mobilization is generally considered in 80% of centers, but early postoperative nutrition on postoperative day 1 (POD 1) in distal gastrectomy is routine in only one center (5%), with 25% of centers still initiating a postoperative diet on POD 4. This attitude is more pronounced after total gastrectomy where in 70% of centers, an oral diet is resumed after POD 4 (20%) or POD 5 (50%) [Fig. 4]. Again, postoperative immunonutrition was used only in malnourished patients in 45% of centers with 40% never using it.
Table 4.
Postoperative items
| Use of opioids n° of centers (%) | |
|---|---|
| Never | 3 (15) |
| Sometimes | 16 (80) |
| Always | 1 (5) |
| Patient mobilization | |
| Within POD 1 | 16 (80) |
| After POD 1 | 2 (10) |
| When possible | 2 (10) |
| Respiratory physiotherapy | |
| Routine, with physiotherapist | 3 (15) |
| Routine, surgeon advices | 8 (40) |
| Selective | 9 (45) |
| Stop infusions | |
| POD 3–4 | 13 (65) |
| After | 7 (35) |
| What instrumental check before the removal of the nasogastric tube? | |
| None | 12 (60) |
| X-ray with gastrografin | 7 (35) |
| Other | 1 (5) |
| Other | 1 (5) |
| Postoperative diet initiation (distal gastrectomy) | |
| POD 1 | 1 (5) |
| POD 2 | 6 (30) |
| POD 3 | 7 (35) |
| POD ≥ 4 | 5 (25) |
| Upon gas passage | 1 (5) |
| Postoperative diet initiation (total gastrectomy) | |
| POD 1 | 1 (5) |
| POD 2 | 2 (10) |
| POD 3 | 2 (10) |
| POD 4 | 4 (20) |
| POD ≥ 5 | 10 (50) |
| Upon gas passage | 1 (5) |
| Postoperative immunonutrition | |
| Never | 8 (40) |
| Only if malnutrition | 9 (45) |
| Always | 1 (5) |
| Other | 1 (5) |
Fig. 4.

Postoperative diet initiation
Discussion
ERAS programs have demonstrated safety and efficacy in the perioperative care of many patients undergoing resective surgery for gastrointestinal cancers [6]. ERAS programs have also been applied to the care of patients undergoing gastrectomy for GC with good results, as reported by several retrospective [9, 12] and prospective [13, 14] series and by several reviews and meta-analyses [7, 8, 15, 16]. These studies have demonstrated that the application of ERAS programs in this setting may reduce hospital stay, costs, and surgical stress response, without increasing postoperative morbidity [8]. Patients treated according to ERAS principles can expect faster recovery and fewer complications and may live longer; health systems can expect reduced cost of care [6]. A higher rate of hospital readmission has been reported in several of these experiences [8] even if only considering patients aged over 75 years [17].
However, other studies have reported how, despite the demonstrated advantages of the applications of ERAS protocol for gastrectomy, their actual applications in daily practice is lower than expected [18, 19]. It is interesting to note that most studies in the literature on the efficacy of a structured ERAS protocol in gastric resective surgery come from the East [20].
In 2019, a nationwide survey in Korea demonstrated that at that time, only 50% of centers performing gastric resective surgery for cancers were applying an ERAS protocol [21]. This situation may be related to the hesitation of surgeons to introduce radical changes to the traditional postoperative management after gastrectomy, mainly due to concerns regarding the problems of tubes (nasogastric tube and drains) and of nutrition.
Therefore, we were interested in analyzing the adoption of the ERAS protocol for gastrectomy among surgical centers in Italy, where the incidence of GC is lower than that in Korea but still remains an important disease in the departments of general and digestive surgery. Gastric resective surgery for cancer in Italy has no centralization [22]. Data from 2019 demonstrated that 5.824 operations for GC were performed in 534 centers. Among them, 249 centers (46.6%) performed less than five resections/year; 27.4% had a volume of at least 20 resections/year [23]. We envision that application of the ERAS protocol for gastric resections could be more diffuse among centers with a minimal volume of 20 cases/year, and selected centers affiliated with the GIRCG took part in this survey, considering their possible interest in this subject.
Generally speaking, a specific interest in the perioperative care of these patients was evident since, at the time of the survey, 65% of centers had a structured protocol for the management of patients undergoing GC surgery. However in most of these centers, application of the perioperative protocol was not shared by all of the professionals included in the pathway, and the definition and application of the items of the ERAS protocol were either at the complete discretion of a single healthcare professional or not included in the perioperative routine. This means that only a few centers, at the time of the survey, were effectively sharing the protocol with audits among the various professionals involved. Implementation of ERAS, as reported by others, should be systematic and involve a multidisciplinary team [6, 24]. Multidisciplinary work, patient partnership, evidence-based interventions, and audit are essential elements for the implementation of ERAS programs; these audits should include monitoring and reviews of outcomes during multidisciplinary meetings. Therefore, in many Italian centers, the application of ERAS programs at the time of the survey should be considered with caution.
We should, however, consider that beyond improving the results of surgery for GC, the application of ERAS programs has been more effective when patients were operated on laparoscopically [16]. In Italy, most resections are performed for locally advanced cancers, mainly after perioperative chemotherapy; in these cases, laparoscopic surgery is still not considered a routine approach as per guidelines [25]. This aspect may in part explain the reluctancy of surgeons to apply the ERAS protocol to their gastrectomies. Thirty percent of the centers included in this survey never or occasionally considered laparoscopic surgery for their resections.
However, ERAS programs have also proven to be effective after open surgery with a reduction of postoperative infections [10] and acceleration of patients’ postoperative recovery [8, 26]. The applications of ERAS programs, in patients treated with open surgery, can improve patients’ recovery and reduce hospital costs without increasing readmission or the need for postdischarge care [25]. Several items in the ERAS programs encompass nutritional problems [27]. Management of the metabolic stress response to surgery is a crucial feature of ERAS protocols; malnutrition and frailty significantly contribute to postoperative morbidity, and nutritional status is a critical factor for recovery after gastrectomy. The prevalence of malnutrition in patients with gastroesophageal cancers [28] is higher than 20%. Therefore, it is usually considered adequate that all patients scheduled for resective gastric surgery require a nutritional risk assessment, and if needed, a preoperative nutritional treatment [29]. In this respect, our survey showed that all participants underwent a preoperative nutritional risk assessment even if a dietary assessment was performed in most centers only in the case of diagnosis of malnutrition. Notwithstanding this, a preoperative long fasting is still considered routine in many centers, probably as a reflection of the absence of a multidisciplinary approach to this problem.
The efficacy of preoperative immune modulating nutrition in reducing postoperative infections has been evaluated by several studies. Although the benefits of immunonutrition in this domain have been reported, [30] no conclusive data are available. More data are available on the benefits of preoperative carbohydrate load, which mitigates the negative effects of overnight fasting [31] and reduces postoperative insulin resistance, with a positive effect on muscle function. A reduction in postoperative stay has been reported for preoperative carbohydrate load in major abdominal surgery [32]. Immunonutrition and carbohydrate-rich drinks are used selectively in most Italian centers with both being routinely used as suggested in the European guidelines [27] in only six centers (30%) [Fig. 1].
Regarding the use of a nasogastric tube after resective surgery, there are ERAS experiences [33], randomized studies [34], systematic reviews [35], and meta-analyses [36] proving that nasogastric decompression is unnecessary after gastrectomy [Fig. 2]. Still, at the time of the survey, a nasogastric tube was inserted in 60% of the participating centers either in all gastric resections (50%) or selectively based on the type of resection (15%); both attitudes were in contrast with the recommendations of the ERAS Society [27]. The use of an abdominal drainage after gastrectomy was considered routine in most centers at the time of the survey. In the same period, a multicenter prospective randomized trial was developed among the GIRCG centers for patients undergoing gastrectomy for GC [37]. This item will, therefore, be implemented in the various centers based on the results of this trial.
Another very important item in the ERAS protocol is the implementation of early postoperative enteral nutrition, which seems to be effective in accelerating postoperative recovery [38]. Traditional postoperative fasting was still considered routine in most centers at the time of the survey, with 25% of centers initiating a postoperative diet on POD 4 after subtotal gastrectomy and 70% of centers resuming an oral diet on POD 4 (20%) or POD 5 (50%) [Fig. 4]. Postoperative fasting proved ineffective in reducing postoperative complications after elective gastrointestinal surgery, as demonstrated by several randomized studies and meta-analyses [39, 40]. Effectively in our survey, particular attention toward malnutrition and early postoperative enteral feeding was demonstrated by the routine use of a jejunostomy or a naso-jejunal feeding tube in the case of malnourished patients in 50% of centers, with 30% using it routinely in the case of total gastrectomy. The analysis of the results of our survey showed that several evidence-based practices and many items of the ERAS guidelines for gastric surgery were not implemented in real practice in Italian centers with a particular interest in GC surgery at the time of the survey. This is in contrast with another experience within the GIRCG, which demonstrated that there is a significant association between adherence to the ERAS protocol and postoperative outcomes [19].
This analysis was done during the SARS-COV2 pandemic infection, a period when elective surgery was limited in numbers and faced a "disrupted" routine. According to published experiences, during the COVID period, adherence to a structured ERAS protocol has been non-homogeneous, even if the data from the literature are few and discordant [41–44].
The fact that our analysis was performed during this pandemic period did not influence our results since the aim of our research was to establish the existence of specific ERAS programs for oncologic gastric surgery in Italian centers with a particular interest in this aspect and not the results of the application of ERAS protocols.
Conclusions
Our survey showed that the application of ERAS programs in Italian centers with a particular interest in GC is occasional; many important items of the ERAS guidelines are not followed even in the presence of evidence-based data supporting them. One of the main problems in the application of these programs is probably the difficulty in applying a multidisciplinary approach to both defining and evaluating the clinical pathway for these patients. Acceptance of the protocol, registration of patients’ data, and periodical audits aimed at discussing the results obtained are the key to success in the application of ERAS philosophy.
Acknowledgements
GIRCG (The Italian Research Group for Gastric Cancer) Members Participating in the Survey. Stefano Rausei, MD, General Surgery Gallarate, Italy. Lapo Bencini, Oncologic Surgery, Azienda Ospedaliero-Universitaria Careggi Firenze, Italy. Eugenio Cocozza, General Oncologic and Minimally Invasive Surgery, ASST Settelaghi,Varese, Italy. Christian Cotsoglou, General Surgery ASST Brianza Vimercate, Italy. Maurizio Degiuli, Surgical Oncology and Digestive Surgery, Department of Oncology, University of Turin, San Luigi University Hospital, Orbassano, Turin, Italy. Giovanni De Palma, Department of Gastroenterology, Endocrinology and Endoscopic Surgery, University Hospital of Naples Federico II, Naples, Italy. Giorgio Ercolani, General and Oncologic Surgery Ospedale Morgagni-Pierantoni Forlì, Italy. Giovanni Ferrari, General Surgery, Legnano, Italy; General Oncologic and Minimally Invasive Surgery ASST GOM Niguarda Milano, Italy. Alessandro Lucianetti, General Surgery, Papa Giovanni XXIII Bergamo, Italy. Federico Marchesi, University of Parma, Department of Medicine and Surgery, School of General Surgery; Parma, Italy. Stefano Merigliano, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Clinica Chirurgica 3, Padova, Italy. Paolo Millo, SC Chirurgia Generale e Urgenza, Ospedale Regionale U. Parini, Aosta, Italy. Giuseppe Navarra, General and Oncologic Surgery AOU G. Martino Messina, Italy. Roberto Petri -General Surgery Azienda Sanitaria Universitaria Friuli Centrale Udine, Italy. Nazario Portolani, Surgical Clinic-,University of Brescia, General Surgery ASST Spedali Civili,Brescia, Italy. Alessandro Puzziello, General Surgery, Ospedale San Giovanni di Dio Salerno, Italy. Riccardo Rosati, Department of Gastrointestinal Surgery, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy. Jacopo Weindelmayer-Division of General and Upper GI Surgery, Department of Surgery, University of Verona, Verona, Italy. Stefano Rausei, Lapo Bencini, Eugenio Cocozza, Christian Cotsoglou, Maurizio Degiuli, Giovanni De Palma, Giovanni Ferrari, Alessandro Lucianetti, Federico Marchesi, Stefano Merigliano, Paolo Millo, Giuseppe Navarra, Roberto Petri, Nazario Portolani, Alessandro Puzziello, Riccardo Rosati, Jacopo Weindelmayer.
Declarations
Conflict of interest
The authors have no conflicts of interest to declare about the present study.
Ethical approval
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with 1964 Helsinki Declaration.
Footnotes
Collaborators are listed in Acknowledgements.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Stefano De Pascale, Email: stefano.depascale@ieo.it.
GIRCG:
Stefano Rausei, Lapo Bencini, Eugenio Cocozza, Christian Cotsoglou, Maurizio Degiuli, Giovanni Palma, Giovanni Ferrari, Alessandro Lucianetti, Federico Marchesi, Stefano Merigliano, Paolo Millo, Giuseppe Navarra, Roberto Petri, Nazario Portolani, Alessandro Puzziello, Riccardo Rosati, Jacopo Weindelmayer, Giorgio Ercolani, and Giovanni De Palma
References
- 1.Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248. doi: 10.2147/CMAR.S14961910.2147/CMAR.S149619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric Cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203. doi: 10.1007/s10555-020-09925-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Solsky I, In H. Surgical treatment for gastric cancer. Gastrointest Endosc Clin N Am. 2021;31(3):581–605. doi: 10.1016/j.giec.2021.04.001. [DOI] [PubMed] [Google Scholar]
- 4.Baiocchi GL, Giacopuzzi S, Reim D, et al. Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry: a European Retrospective Observational Study. Ann Surg. 2020;272(5):807–813. doi: 10.1097/SLA.0000000000004341. [DOI] [PubMed] [Google Scholar]
- 5.Wang S, Xu L, Wang Q, et al. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol. 2019;17(1):52. doi: 10.1186/s12957-019-1593-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292–298. doi: 10.1001/jamasurg.2016.4952. [DOI] [PubMed] [Google Scholar]
- 7.Zhang X, Yang J, Chen X, Du L, Li K, Zhou Y. Enhanced recovery after surgery on multiple clinical outcomes Umbrella review of systematic reviews and meta-analyses. Medicine. 2020;99(29):e20983. doi: 10.1097/MD.0000000000020983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wee IJY, Syn NL, Shabbir A, Kim G, So JBY. Enhanced recovery versus conventional care in gastric cancer surgery: a meta-analysis of randomized and non-randomized controlled trials. Gastric Cancer. 2019;22(3):423–434. doi: 10.1007/s10120-019-00937-9. [DOI] [PubMed] [Google Scholar]
- 9.Wang J, Luo Y, Wang Q, et al. Evaluation of the application of laparoscopy in enhanced recovery after surgery (ERAS) for gastric cancer: a Chinese multicenter analysis. Ann Transl Med. 2008;8(8):543. doi: 10.21037/atm-20-2556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jeong O, Jang A, Jung MR, Kang JH, Ryu SY. The benefits of enhanced recovery after surgery for gastric cancer: a large before-and-after propensity score matching study. Clin Nutr. 2021;40(4):2162–2168. doi: 10.1016/j.clnu.2020.09.042. [DOI] [PubMed] [Google Scholar]
- 11.Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc ESPEN Working Group Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321–336. doi: 10.1016/s0261-5614(02)00214-5. [DOI] [PubMed] [Google Scholar]
- 12.Desiderio J, Stewart CL, Sun V, et al. Enhanced recovery after surgery for gastric cancer patients improves clinical outcomes at a US cancer center. J Gastric Cancer. 2018;18(3):230–241. doi: 10.5230/jgc.2018.18.e24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jung MR, Ryu SY, Park YK, Jeong O. Compliance with an enhanced recovery after a surgery program for patients undergoing gastrectomy for gastric carcinoma: a phase 2 study. Ann Surg Oncol. 2018;25:2366–2373. doi: 10.1245/s10434-018-6524-4. [DOI] [PubMed] [Google Scholar]
- 14.Tanaka R, Lee SW, Kawai M, et al. Protocol for enhanced recovery after surgery improves short-term outcomes for patients with gastric cancer: a randomized clinical trial. Gastric Cancer. 2017;20:861–871. doi: 10.1007/s10120-016-0686-1. [DOI] [PubMed] [Google Scholar]
- 15.Huang ZD, Gu HY, Zhu J, et al. The application of enhanced recovery after surgery for upper gastrointestinal surgery: meta-analysis. BMC Surg. 2020;20(1):3. doi: 10.1186/s12893-019-0669-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li Z, Wang Q, Li B, Bai B, Zhao Q. Influence of enhanced recovery after surgery programs on laparoscopy-assisted gastrectomy for gastric cancer: a systematic review and meta-analysis of randomized control trials. World J Surg Oncol. 2017;15(1):207. doi: 10.1186/s12957-017-1271-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang LH, Zhu RF, Gao C, Wang SL, Shen LZ. Application of enhanced recovery after gastric cancer surgery: an updated meta-analysis. World J Gastroenterol. 2018;24(14):1562–1578. doi: 10.3748/wjg.v24.i14.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fumagalli Romario U, Weindelmayer J, Coratti A, et al. Enhanced recovery after surgery in gastric cancer: which are the main achievements from the Italian experience? Updates Surg. 2018;70(2):257–264. doi: 10.1007/s13304-018-0522-8. [DOI] [PubMed] [Google Scholar]
- 19.Gianotti L, Fumagalli Romario U, De Pascale S, et al. Association between compliance to an enhanced recovery protocol and outcome after elective surgery for gastric cancer. Results from a western population-based prospective multicenter study. World J Surg. 2019;43(10):2490–2498. doi: 10.1007/s00268-019-05068-x. [DOI] [PubMed] [Google Scholar]
- 20.Salvans S, Grande L, Dal Cero M, Pera M. State of the art of enhance recovery after surgery (ERAS) protocols in esophagogastric cancer surgery: the Western experience. Updates Surg. 2022 doi: 10.1007/s13304-022-01311-8. [DOI] [PubMed] [Google Scholar]
- 21.Jeong O, Kim HG. Implementation of enhanced recovery after surgery (ERAS) program in perioperative management of gastric cancer surgery: a nationwide survey in Korea. J Gastric Cancer. 2019;19(1):72–82. doi: 10.5230/jgc.2019.19.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lorenzon L, Biondi A, Agnes A, Scrima O, Persiani R, D'Ugo D. Quality over volume: modeling centralization of gastric cancer resections in Italy. J Gastric Cancer. 2022;22(1):35–46. doi: 10.5230/jgc.2022.22.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Project PNE (Piano Nazionale Esiti) by the National Agency for Regional Health Services (AGENAS) Available from: https://pne.agenas.it/. Accessed 04 May 2022
- 24.Yamagata Y, Yoshikawa T, Yura M, et al. Current status of the “enhanced recovery after surgery” program in gastric cancer surgery. Ann Gastroenterol Surg. 2019;3(3):231–238. doi: 10.1002/ags3.12232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.De Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20(1):20–30. doi: 10.1007/s10120-016-0615-3. [DOI] [PubMed] [Google Scholar]
- 26.Weindelmayer J, Mengardo V, Gasparini A, et al. (2021) Enhanced recovery after surgery can improve patient outcomes and reduce hospital cost of gastrectomy for cancer in the west: a propensity-score-based analysis. Ann Surg Oncol. 2021;28:7087–7094. doi: 10.1245/s10434-021-10079-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mortensen K, Nilsson M, Slim K, et al. Consensus guidelines for enhanced recovery after gastrectomy Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg. 2014;101(10):1209–1229. doi: 10.1002/bjs.9582. [DOI] [PubMed] [Google Scholar]
- 28.Rosania R, Chiapponi C, Malfertheiner P, Venerito M. Nutrition in patients with gastric cancer: an update. Gastrointest Tumors. 2016;2(4):178–187. doi: 10.1159/000445188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lobo DN, Gianotti L, Adiamah A, et al. Perioperative nutrition: recommendations from the ESPEN expert group. Clin Nutr. 2020;39(11):3211–3227. doi: 10.1016/j.clnu.2020.03.038. [DOI] [PubMed] [Google Scholar]
- 30.Adiamah A, Skořepa P, Weimann A, Lobo DN. The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Ann Surg. 2019;270(2):247–256. doi: 10.1097/SLA.0000000000003256. [DOI] [PubMed] [Google Scholar]
- 31.Fawcett WJ, Thomas M. Pre-operative fasting in adults and children: clinical practice and guidelines. Anaesthesia. 2019;74(1):83–88. doi: 10.1111/anae.14500. [DOI] [PubMed] [Google Scholar]
- 32.Gianotti L, Biffi R, Sandini M, et al. Preoperative oral carbohydrate load versus placebo in major elective abdominal surgery (PROCY): a randomized, placebo-controlled, multicenter phase III trial. Ann Surg. 2018;267(4):623–630. doi: 10.1097/SLA.0000000000002325. [DOI] [PubMed] [Google Scholar]
- 33.Yamada T, Hayashi T, Cho H, et al. Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer. 2012;15(1):34–41. doi: 10.1007/s10120-011-0057-x. [DOI] [PubMed] [Google Scholar]
- 34.Carrère N, Seulin P, Julio CH, Bloom E, Gouzi JL, Pradère B. Is nasogastric or nasojejunal decompression necessary after gastrectomy? A prospective randomized trial. World J Surg. 2007;31(1):122–127. doi: 10.1007/s00268-006-0430-9. [DOI] [PubMed] [Google Scholar]
- 35.Wei ZW, Li JL, Li ZS, et al. Systematic review of nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Eur J Surg Oncol. 2014;40(12):1763–1770. doi: 10.1016/j.ejso.2014.05.013. [DOI] [PubMed] [Google Scholar]
- 36.Yang Z, Zheng Q, Wang Z. Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Br J Surg. 2008;95(7):809–816. doi: 10.1002/bjs.6198. [DOI] [PubMed] [Google Scholar]
- 37.Weindelmayer J, Mengardo V, Veltri A, et al. Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial. Trials. 2021;22(1):152. doi: 10.1186/s13063-021-05102-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hur H, Kim SG, Shim JH, et al. Effect of early oral feeding after gastric cancer surgery: a result of randomized clinical trial. Surgery. 2011;149(4):561–568. doi: 10.1016/j.surg.2010.10.003. [DOI] [PubMed] [Google Scholar]
- 39.Lewis SJ, Egger M, Sylvester PA, Thomas S. Early enteral feeding versus “nil by mouth” after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ. 2001;323(7316):773–776. doi: 10.1136/bmj.323.7316.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Willcutts KF, Chung MC, Erenberg CL, Finn KL, Schirmer BD, Byham-Gray LD. Early oral feeding as compared with traditional timing of oral feeding after upper gastrointestinal surgery: a systematic review and meta-analysis. Ann Surg. 2016;264(1):54–63. doi: 10.1097/SLA.0000000000001644. [DOI] [PubMed] [Google Scholar]
- 41.Borghi F, Pellegrino L, Pruiti V, Donati D, Giraudo G. Feasibility of enhanced recovery after surgery program in colorectal surgery during COVID-19 pandemic in Italy: should we change something? Updates Surg. 2020;72(2):319–320. doi: 10.1007/s13304-020-00827-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Goodmaker CJG, Kopczynska M, Meskell R, Slade D. Paving the road to recovery: the colorectal surgery ERAS pathway during the COVID-19 pandemic. Br J Surg. 2021;108(10):e322–e323. doi: 10.1093/bjs/znab208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sica GS, Campanelli M, Bellato V, Monteleone G. Gastrointestinal cancer surgery and enhanced recovery after surgery (ERAS) during COVID-19 outbreak. Langenbecks Arch Surg. 2020;405(3):357–358. doi: 10.1007/s00423-020-01885-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Grieco M, Galiffa G, Marcellinaro R, et al. Impact of the COVID-19 pandemic on enhanced recovery after surgery (ERAS) application and outcomes: analysis in the "Lazio Network" database. World J Surg. 2022;46(10):2288–2296. doi: 10.1007/s00268-022-06694-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
